Cialis / Tadalafil
Icos Corp. and Eli Lilly and Co. await Federal Drug Administration (FDA) approval of their new erectile dysfunction (ED) drug, Cialis. Cialis appears to be effective in the treatment of men with diabetes-related ED. Sixty-four percent of diabetics who took Cialis during clinical trials showed erectile performance improvements. Patients suffering from diabetes often complain of problems associated with impotence as diabetes impedes blood flow to the penis.
Side effects of the drug include, but may not be limited to, headache and dyspepsia. Recently, the FDA issued a warning to Icos and Eli Lilly concerning misinformation that company representatives disseminated about Cialis. The drug makers promoted Cialis as "safe and effective" for the treatment of ED. The FDA considers such statements to be inappropriate since the agency has not yet officially approved the drug.
-- Article Courtesy of InjuryBoard.com
More ...
- Erectile Dysfunction Drugs: Overview
- The Pros and Cons of Viagra
- "Study Explains Viagra's Link to Heart Attacks, Strokes"
.